CREB1 and Parkinson disease: Post-mortem brain analysis in humans and animal models have found decreased CREB expression associated with many neurological and neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, bipolar disorder, and schizophrenia [31, 103–105].